Epstein-barr virus-positive diffuse large b-cell lymphomas of the elderly

Advances in Anatomic Pathology

Volumn 18, Issue 5, 2011, Pages 349-355

  Adam, Patrick ^a   Bonzheim, Irina ^a   Fend, Falko ^a   Quintanilla Martínez, Leticia ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

diffuse large B cell lymphoma; Epstein Barr virus; immune senescence

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BOB 1; UNCLASSIFIED DRUG;

CELL PROLIFERATION; CELL TRANSFORMATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENOTYPE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOCYTE; MOLECULAR CLONING; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; REVIEW; SENESCENCE;

AGED; CELL AGING; CLONE CELLS; DIAGNOSIS, DIFFERENTIAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED; PLASMA CELLS; REED-STERNBERG CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 80052016959     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e318229bf08     Document Type: Review

References (25)

1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet. 1964;1: 702-703.
2. Shah KM, Young LS. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma. Clin Microbiol Infect. 2009;15: 982-988.
3. Oyama T, Ichimura K, Suzuki R, et al. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol. 2003;27:16-26. (Pubitemid 36014895)
4. Oyama T, Yamamoto K, Asano N, et al. Age-related EBVassociated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res. 2007;13:5124-5132. (Pubitemid 47502080)
5. Swerdlow SH, Harris NL, Jaffe ES, et al, eds. World Health Organization Classification of Tumours WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008.
6. Nakamura S, Jaffe ES, Swerdlow SH. EBV positive diffuse large B-cell lymphoma of the elderly. In: Swerdlow SH, Harris NL, Jaffe ES, et al, eds. World Health Organization Classification of Tumours WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC Press; 2008.
7. Kuze T, Nakamura N, Hashimoto Y, et al. The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(-) cases in Japanese population. Jpn J Cancer Res. 2000;91:1233-1240. (Pubitemid 32042357)
8. Park S, Lee J, Ko YH, et al. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood. 2007;110:972-978. (Pubitemid 47267436)
9. Gibson SE, Hsi ED. Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. Hum Pathol. 2009;40:653-661.
10. Hoeller S, Tzankov A, Pileri SA, et al. Epstein-Barr viruspositive diffuse large B-cell lymphoma in elderly patients is rare in Western populations. Hum Pathol. 2010;41:352-357.
11. Hofscheier A, Ponciano A, Bonzheim I, et al. Geographic variation in the prevalence of Epstein-Barr Virus-positive diffuse large B-Cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population. Mod Pathol. 2011: prepublished online (15 April 2011) | doi:10.1038
12. Cohen JI, Kimura H, Nakamura S, et al. Epstein-Barr virusassociated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8 to 9 September 2008. Ann Oncol. 2009;20: 1472-1482.
13. Yasunaga J, Sakai T, Nosaka K, et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood. 2001;97:3177-3183.
14. Fagnoni FF, Vescovini R, Passeri G, et al. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood. 2000;95:2860-2868. (Pubitemid 30235896)
15. Ouyang Q, Wagner WM, Walter S, et al. An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech Ageing Dev. 2003;124:477-485. (Pubitemid 36519208)
16. Cen H, Williams PA, McWilliams HP, et al. Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders. Blood. 1993;81:1393-1403. (Pubitemid 23067380)
17. Shimoyama Y, Asano N, Kojima M, et al. Age-related EBVassociated B-cell lymphoproliferative disorders: diagnostic approach to a newly recognized clinicopathological entity. Pathol Int. 2009;59:835-843.
18. Shimoyama Y, Yamamoto K, Asano N, et al. Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci. 2008;99: 1085-1091. (Pubitemid 351676618)
19. Quintanilla-Martinez L, de Jong D, de Mascarel A, et al. Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux. France. J Hematop. 2009;2:211-236.
20. Asano N, Yamamoto K, Tamaru J, et al. Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood. 2009;113:2629-2636.
21. Wong HH, Wang J. Epstein-Barr virus positive diffuse large B-cell lymphoma of the elderly. Leuk Lymphoma. 2009;50: 335-340.
22. Dirnhofer S, Angeles-Angeles A, Ortiz-Hidalgo C, et al. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue. Hum Pathol. 1999;30:781-787. (Pubitemid 29325784)
23. Kojima M, Kashimura M, Itoh H, et al. Epstein-Barr virusrelated reactive lymphoproliferative disorders in middle-aged or elderly patients presenting with atypical features. A clinicopathological study of six cases. Pathol Res Pract. 2007;203:587-591. (Pubitemid 47163499)
24. Pittaluga S WWH, Jaffe E. Lymphomatoid granulomatosis. In: Swerdlow SH, Harris NL, Jaffe ES, et al, eds. World Health Organization Classification of Tumours WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC Press; 2008.
25. Stein H HNL, Campo E. Plasmablastic lymphoma. In: Swerdlow SH, Harris NL, Jaffe ES, et al, eds. World Health Organization Classification of Tumours WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC Press; 2008.